MOTS-C 30mg
Mitochondrial-derived peptide — metabolic flexibility and insulin sensitivity
BioBlend Pharma Grade3ml vialMitochondrial Metabolism
MOTS-C 30mg
Mitochondrial-derived peptide — metabolic flexibility and insulin sensitivity
Contact for pricing
Administration
Injectable
First Results
2–4 weeks
Cycle Length
8–12 weeks
Clinical Uses
- Metabolic syndrome and insulin resistance
- Type 2 diabetes support
- Obesity and visceral fat
- Exercise performance enhancement
- Mitochondrial dysfunction and fatigue
Key Benefits
- Activates AMPK master metabolic enzyme
- Exercise-mimetic metabolic effects
- Improves insulin sensitivity safely
- Reduces visceral fat, preserves lean mass
- Mitochondrially encoded — unique mechanism
How It Works — Mechanism of Action
MOTS-c activates AMPK and regulates glucose and fatty acid metabolism, increasing GLUT4 translocation, activating PGC-1α and improving whole-body insulin sensitivity.
Your MOTS-C 30mg protocol, wherever you are
A pre-filled, easy-to-carry pen for self-administration at home, the gym or the office. Dispensed safely after physician approval and delivered cold-chain to you.
Dosage Protocol
5–10 mg subcutaneous 3–5x per week, morning before exercise. 8–12 weeks.
When to Expect Results
Week 1–2: improved energy. Weeks 2–4: fasting glucose gains. Weeks 8–12: panel normalisation.
Side Effects
Generally well tolerated. Rare: mild injection-site redness. Contact your physician for any unusual symptom.
Contraindications
Active cancer, pregnancy, hypersensitivity to peptide components. Always review with your physician.
Best Stacked With
Consult your physician for synergistic stacking options matched to your goal.
Understanding Your Body’s Language
Ready to start your MOTS-C 30mg protocol?
All peptide protocols require a physician consultation and blood work. Our licensed UAE team will craft a personalised plan for you.
Book a consultation